Nichi-Iko Pharmaceutical Co (Nichi-Iko Pharmaceutical Co) EV-to-Revenue : 1.00 (As of May. 04, 2024)

Nichi-Iko Pharmaceutical Co EV-to-Revenue Chart

Nichi-Iko Pharmaceutical Co Annual Data
	Trend	Mar13	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22
EV-to-Revenue		Get a 7-Day Free Trial					1.19	1.08	0.96	0.96	1.13

Nichi-Iko Pharmaceutical Co Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
EV-to-Revenue	Get a 7-Day Free Trial															1.05	1.13	1.04	1.18	1.07

Competitive Comparison of Nichi-Iko Pharmaceutical Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Nichi-Iko Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nichi-Iko Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nichi-Iko Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nichi-Iko Pharmaceutical Co's EV-to-Revenue falls into.

Nichi-Iko Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Nichi-Iko Pharmaceutical Co's EV-to-Revenue for today is calculated as:

Nichi-Iko Pharmaceutical Co's current Enterprise Value is $1,385 Mil.
Nichi-Iko Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,384 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nichi-Iko Pharmaceutical Co  (OTCPK:NHKFF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Nichi-Iko Pharmaceutical Co's PS Ratiofor today is calculated as:

Nichi-Iko Pharmaceutical Co's share price for today is $25268107.30.
Nichi-Iko Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $21.58.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nichi-Iko Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nichi-Iko Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nichi-Iko Pharmaceutical Co (Nichi-Iko Pharmaceutical Co) Business Description